LYEL logo

Lyell Immunopharma, Inc.

LYEL
Healthcare|Biotechnology|US
$14.86
-0.14 (-0.93%)
DCF Value
$0.36
Tangible Book / Share
$7.89
Cash / Share
$7.25

Ownership Breakdown

59.7%
Float
24.5M
Shares Outstanding
14.6M
Float Shares

Major Holders (37)

Combined: 294.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
ARCH Venture Partners XIII, L.P.Partnership13.90%3,247,162May 15, 202613D/G
ARCH Venture Partners XIII, LLCOther13.90%3,247,162May 15, 202613D/G
Keith CrandellIndividual13.90%3,247,162May 15, 202613D/G
Robert NelsenIndividual13.90%3,247,162May 15, 202613D/G
Kristina BurowIndividual13.90%3,247,162May 15, 202613D/G
Steven GillisIndividual13.90%3,247,162May 15, 202613D/G
ARCH Venture Partners IX Overage, L.P.Partnership13.90%3,247,162May 15, 202613D/G
ARCH Venture Partners IX, L.P.Partnership13.90%3,247,162May 15, 202613D/G
ARCH Venture Partners IX, LLCOther13.90%3,247,162May 15, 202613D/G
ARCH Venture Fund IX, L.P.Partnership13.90%3,247,162May 15, 202613D/G
ARCH Venture Fund IX Overage, L.P.Partnership13.90%3,247,162May 15, 202613D/G
ARCH Venture Fund XIII, L.P.Partnership13.90%3,247,162May 15, 202613D/G
Innovative Cellular Therapeutics Holdings LimitedOther12.30%3,000,000Jun 18, 202613D/G
Innovative Cellular Therapeutics Holdings LtdOther9.80%1,900,000Nov 13, 202513D/G
Clinton BybeeIndividual7.80%1,820,634May 15, 202613D/G
Euler Managers LimitedCorporation6.71%1,426,528Apr 21, 202613D/G
Antonis IndianosIndividual6.71%1,426,528Apr 21, 202613D/G
Euler Fund, L.P.Partnership6.71%1,426,528Apr 21, 202613D/G
James TananbaumIndividual6.70%19,478,893Feb 14, 202513D/G
Explore Investments LLCOther6.60%1,529,054May 8, 202613D/G
Jeffrey P. BezosIndividual6.60%1,529,054May 8, 202613D/G
Paul BernsIndividual6.10%1,426,528May 15, 202613D/G
William H. Gates IIIIndividual5.60%1,040,964Aug 1, 202513D/G
Gates Frontier, LLCOther5.60%1,040,964Aug 1, 202513D/G
BlackRock, Inc.Holding company4.50%13,265,869Feb 5, 202513D/G
MWG Caph LtdCorporation4.30%1,008,116May 11, 202613D/G
Milky Way Investments Group Ltd.Corporation4.30%1,008,116May 11, 202613D/G
Orland Properties LimitedCorporation3.93%754,698Nov 12, 202513D/G
Gemini GP LimitedCorporation3.93%754,698Nov 12, 202513D/G
Gemini Investments, L.P.Partnership3.93%754,698Nov 12, 202513D/G
Newton (PTC) LimitedCorporation3.93%754,698Nov 12, 202513D/G
The Vanguard GroupInvestment adviser3.93%10,071,482Nov 12, 202413D/G
James B. TananbaumIndividual2.70%653,328Aug 14, 202613D/G
Foresite Capital Management V, LLCOther1.90%476,386Aug 14, 202613D/G
Foresite Capital Fund V, L.P.Partnership1.90%476,386Aug 14, 202613D/G
Foresite Capital Opportunity Management V, LLCOther0.70%176,942Aug 14, 202613D/G
Foresite Capital Opportunity Fund V, L.P.Partnership0.70%176,942Aug 14, 202613D/G

Insider Trades (100)

Last 4 quarters: 6,277,704 acquired · 253,319 disposed
InsiderPositionDateTypeSharesPriceValueFiling
ARCH Venture Partners IX, LLC10 percent ownerNov 4, 2026BUY2,321,262$10.77$25.0MForm 4
ARCH Venture Fund XIII, L.P.10 percent ownerNov 4, 2026BUY2,321,262$10.77$25.0MForm 4
Aguirre Jarrad MattieuChief Medical OfficerOct 12, 2026SELL422$8.63$3.6KForm 4
Shook DavidChief Medical OfficerSep 10, 2026SELL500$12.70$6.3KForm 4
Aguirre Jarrad MattieuChief Medical OfficerSep 10, 2026AWARD47,500$12.20$579.5KForm 4
Aguirre Jarrad MattieuChief Medical OfficerAug 31, 2026OTHER0——Form 4
Aguirre Jarrad MattieuChief Medical OfficerAug 31, 2026OTHER46,249$11.64$538.3KForm 4
Aguirre Jarrad MattieuChief Medical OfficerAug 31, 2026OTHER35,000$23.71$829.9KForm 4
Aguirre Jarrad MattieuChief Medical OfficerAug 31, 2026OTHER15,000$19.20$288.0KForm 4
Seely Lynndirector, officer: President and CEOAug 21, 2026SELL9,589$15.54$149.0KForm 4
Hill Stephen J.Chief Operating OfficerAug 21, 2026SELL989$15.54$15.4KForm 4
Lee Gary K.Chief Scientific OfficerAug 21, 2026SELL1,457$15.54$22.6KForm 4
Bulis Veronica SanchezVP, Corporate ControllerAug 10, 2026SELL621$14.34$8.9KForm 4
Lee Gary K.Chief Scientific OfficerAug 10, 2026SELL131$14.34$1.9KForm 4
Hill Stephen J.Chief Operating OfficerAug 10, 2026SELL89$14.34$1.3KForm 4
Seely Lynndirector, officer: President and CEOAug 10, 2026SELL390$14.34$5.6KForm 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerJul 27, 2026DISPOSED44,000——Form 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerJul 27, 2026DISPOSED38,500——Form 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerJul 17, 2026SELL10$13.70$137.00Form 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerJul 16, 2026SELL10$13.73$137.30Form 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerJun 29, 2026DISPOSED76,000——Form 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerJun 15, 2026DISPOSED66,500——Form 4
Innovative Cellular Therapeutics Holdings Ltd10 percent ownerMay 18, 2026OTHER0——Form 4
Seely Lynndirector, officer: President and CEOMay 11, 2026SELL388$18.91$7.3KForm 4
Lee Gary K.Chief Scientific OfficerMay 11, 2026SELL130$18.92$2.5KForm 4
Hill Stephen J.Chief Operating OfficerMay 11, 2026SELL89$18.92$1.7KForm 4
Bulis Veronica SanchezVP, Corporate ControllerMay 11, 2026SELL217$18.91$4.1KForm 4
RIEFLIN WILLIAM JLdirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
Ramachandra SumantdirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
NABEL ELIZABETH GdirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
Klausner RicharddirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
FRIEDMAN CATHYdirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
BRAWLEY OTIS WdirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
Bachleda MarkdirectorJun 10, 2026AWARD9,250$13.22$122.3KForm 4
Shook DavidChief Medical OfficerJun 10, 2026SELL1,977$12.64$25.0KForm 4
Shah SmitalChief Fin. and Bus. OfficerMar 9, 2026AWARD140,000$25.50$3.6MForm 4
Shah SmitalMar 9, 2026OTHER0——Form 4
ARCH Venture Partners IX, LLC10 percent ownerMar 6, 2026BUY488,090$25.61$12.5MForm 4
ARCH Venture Fund XIII, L.P.10 percent ownerMar 6, 2026BUY488,090$25.61$12.5MForm 4
Seely Lynndirector, officer: President and CEOFeb 11, 2026SELL7,455$23.39$174.4KForm 4
Hill Stephen J.Chief Operating OfficerFeb 11, 2026SELL1,236$23.39$28.9KForm 4
Lee Gary K.Chief Scientific OfficerFeb 11, 2026SELL1,671$23.39$39.1KForm 4
Hill Stephen J.Chief Operating OfficerFeb 10, 2026AWARD65,000$23.71$1.5MForm 4
Hill Stephen J.Chief Operating OfficerFeb 9, 2026AWARD4,000——Form 4
Hill Stephen J.Chief Operating OfficerFeb 10, 2026SELL109$23.12$2.5KForm 4
Lee Gary K.Chief Scientific OfficerFeb 10, 2026AWARD50,000$23.71$1.2MForm 4
Lee Gary K.Chief Scientific OfficerFeb 9, 2026AWARD4,000——Form 4
Lee Gary K.Chief Scientific OfficerFeb 10, 2026SELL147$23.12$3.4KForm 4
Seely Lynndirector, officer: President and CEOFeb 10, 2026AWARD155,000$23.71$3.7MForm 4
Seely Lynndirector, officer: President and CEOFeb 9, 2026AWARD20,000——Form 4
Seely Lynndirector, officer: President and CEOFeb 10, 2026SELL438$23.12$10.1KForm 4
Meltz Mark AGeneral CounselFeb 10, 2026AWARD50,000$23.71$1.2MForm 4
Bulis Veronica SanchezVP, Corporate ControllerFeb 10, 2026AWARD8,750——Form 4
Bulis Veronica SanchezVP, Corporate ControllerFeb 10, 2026SELL254$23.12$5.9KForm 4
Shook DavidChief Medical OfficerFeb 10, 2026AWARD50,000$23.71$1.2MForm 4
Bulis Veronica SanchezVP, Corporate ControllerDec 24, 2025SELL1,136$38.67$43.9KForm 4
Bulis Veronica SanchezVP, Corporate ControllerDec 30, 2025SELL936$32.32$30.3KForm 4
Seely Lynndirector, officer: President and CEONov 10, 2025SELL412$16.11$6.6KForm 4
Bulis Veronica SanchezVP, Corporate ControllerNov 10, 2025SELL239$16.10$3.8KForm 4
Lee Gary K.Chief Scientific OfficerNov 10, 2025SELL138$16.16$2.2KForm 4
Hill Stephen J.Chief Operating OfficerNov 10, 2025SELL95$16.12$1.5KForm 4
Bulis Veronica SanchezVP, Corporate ControllerOct 31, 2025OTHER0——Form 4
Bulis Veronica SanchezVP, Corporate ControllerOct 31, 2025OTHER3,000$37.40$112.2KForm 4
Bulis Veronica SanchezVP, Corporate ControllerOct 31, 2025OTHER1,674$42.60$71.3KForm 4
Hill Stephen J.Chief Operating OfficerOct 27, 2025AWARD75,000$17.23$1.3MForm 4
Lee Gary K.Chief Scientific OfficerOct 27, 2025AWARD68,000$17.23$1.2MForm 4
Seely Lynndirector, officer: President and CEOOct 27, 2025AWARD175,000$17.23$3.0MForm 4
Seely Lynndirector, officer: President and CEOAug 20, 2025AWARD40,000——Form 4
Seely Lynndirector, officer: President and CEOAug 21, 2025SELL7,257$10.54$76.5KForm 4
Hill Stephen J.Chief Operating OfficerAug 20, 2025AWARD8,000——Form 4
Hill Stephen J.Chief Operating OfficerAug 21, 2025SELL1,004$10.54$10.6KForm 4
Newton Charles W.Chief Financial OfficerAug 20, 2025AWARD8,000——Form 4
Newton Charles W.Chief Financial OfficerAug 21, 2025SELL1,453$10.54$15.3KForm 4
Lee Gary K.Chief Scientific OfficerAug 20, 2025AWARD8,000——Form 4
Lee Gary K.Chief Scientific OfficerAug 21, 2025SELL1,453$10.54$15.3KForm 4
Seely Lynndirector, officer: President and CEOAug 11, 2025SELL391$10.53$4.1KForm 4
Seely Lynndirector, officer: President and CEOAug 12, 2025SELL406$10.34$4.2KForm 4
Hill Stephen J.Chief Operating OfficerAug 11, 2025SELL91$10.53$957.87Form 4
Hill Stephen J.Chief Operating OfficerAug 12, 2025SELL94$10.34$971.77Form 4
Lee Gary K.Chief Scientific OfficerAug 11, 2025SELL131$10.53$1.4KForm 4
Lee Gary K.Chief Scientific OfficerAug 12, 2025SELL136$10.34$1.4KForm 4
Newton Charles W.Chief Financial OfficerAug 11, 2025SELL131$10.53$1.4KForm 4
Newton Charles W.Chief Financial OfficerAug 12, 2025SELL136$10.34$1.4KForm 4
ARCH Venture Partners IX, LLC10 percent owner: Jul 25, 2025OTHER0——Form 4
ARCH Venture Fund XIII, L.P.10 percent ownerJul 25, 2025OTHER0——Form 4
Bachleda MarkdirectorJun 9, 2025AWARD13,000$12.47$162.1KForm 4
Meltz Mark AGeneral CounselJun 9, 2025AWARD100,000$12.47$1.2MForm 4
Shook DavidChief Medical OfficerJun 9, 2025AWARD43,750$12.47$545.6KForm 4
Shook DavidChief Medical OfficerJun 9, 2025AWARD21,900——Form 4
Bachleda MarkJun 9, 2025OTHER0——Form 4
Meltz Mark AJun 9, 2025OTHER0——Form 4
Shook DavidJun 9, 2025OTHER0——Form 4
Klausner RicharddirectorMay 15, 2025AWARD130,000$0.40$52.2KForm 4
RIEFLIN WILLIAM JLdirectorMay 15, 2025AWARD130,000$0.40$52.2KForm 4
FRIEDMAN CATHYdirectorMay 15, 2025AWARD130,000$0.40$52.2KForm 4
BRAWLEY OTIS WdirectorMay 15, 2025AWARD130,000$0.40$52.2KForm 4
NABEL ELIZABETH GdirectorMay 15, 2025AWARD130,000$0.40$52.2KForm 4
Ramachandra SumantdirectorMay 15, 2025AWARD130,000$0.40$52.2KForm 4
BRAWLEY OTIS WdirectorMar 31, 2025BUY35,640$0.56$20.0KForm 4
Ramachandra SumantdirectorMar 21, 2025BUY200,000$0.58$115.2KForm 4